Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Gynaecological Cancers

An Introduction to Gynaecological Cancers

The treatment landscape for gynaecological cancers, especially ovarian cancer, has evolved over recent years. Late diagnosis means ovarian cancer is often detected at an advanced stage, but the introduction of targeted therapies and immunotherapies have widened the treatment landscape. Cervical cancer has a high survival rate if detected early, and therefore screening continues to be an important issue.

Expert video highlights, insights from the conference hub and comprehensive peer-reviewed articles from our journal portfolio provide updates on the changing treatment landscape. To learn more about how the latest developments impact on patient outcomes, view our expert-led learning activities.”

Our supporting partners do not constitute an endorsement of the content on this page.

Mark CompleteCompleted
BookmarkBookmarked

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Mark CompleteCompleted
BookmarkBookmarked

This year, we are celebrating our inaugural touchONCOLOGY Future Leaders to recognize the outstanding talent that has entered our field in recent years. These individuals are set to innovate and transform oncology and haematology in the years to come.

38 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Two experts discuss evolving immunotherapy standards of care in advanced/recurrent endometrial cancer.

35 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Watch two experts discuss HPV-related disease, vaccination scheduling and strategies to increase uptake.

Mark CompleteCompleted
BookmarkBookmarked

As 2024 draws to a close, we’re celebrating a wonderful year of content.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In our latest episode, we delve into the world of space medicine to explore how drug crystallization in microgravity could revolutionize biologic drug administration. Joining us is Dr Katie King, CEO of BioOrbit, to discuss the science, challenges, and technological advancements that could make space-based drug production a reality.

Mark CompleteCompleted
BookmarkBookmarked

Highlights from ESGO 2024, featuring the latest data and insights presented at the meeting.

38 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Hear expert insights on the role of immunotherapy in treating advanced/recurrent endometrial cancer.

Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest issue of touchREVIEWS in Oncology & Haematology. We are honoured to present a series of compelling articles that reflect cutting-edge developments and diverse perspectives in this ever-evolving field. This issue includes a series of editorials and ...

Mark CompleteCompleted
BookmarkBookmarked

The treatment of advanced or recurrent endometrial cancer has advanced significantly in recent years. This is particularly important, given the rising mortality rates of endometrial cancer, particularly among high-risk subtypes.1 Platinum-based chemotherapy had long been the standard of care in ...

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr David O’Malley, Dr Domenica Lorusso, Ms. Courtney Arn

Experts share key guideline recommendations and safety considerations for systemic treatment options.

38 mins
touchMDT
Mark CompleteCompleted
BookmarkBookmarked

Select a discussion in the hub to watch our multidisciplinary team share expert perspectives on the appropriate implementation of immune checkpoint inhibitors through shared decision making to ensure optimal outcomes for patients with endometrial cancer.

Load More...
Close Popup